Recommendation 2003/488 - Prevention and reduction of health-related harm associated with drug dependence - Main contents
Please note
This page contains a limited version of this dossier in the EU Monitor.
Contents
official title
Council Recommendation of 18 June 2003 on the prevention and reduction of health-related harm associated with drug dependence| Legal instrument | Recommendation |
|---|---|
| Number legal act | Recommendation 2003/488 |
| Original proposal | COM(2002)201  |
| CELEX number i | 32003H0488 |
| Document | 18-06-2003 |
|---|---|
| Publication in Official Journal | 03-07-2003; OJ L 165 p. 31-33 |
| Effect | 18-06-2003; Entry into force Date of document |
| End of validity | 31-12-9999 |
|
Council Recommendation of 18 June 2003 on the prevention and reduction of health-related harm associated with drug dependence
Official Journal L 165 , 03/07/2003 P. 0031 - 0033
Council Recommendation
of 18 June 2003
on the prevention and reduction of health-related harm associated with drug dependence
(2003/488/EC)
THE COUNCIL OF THE EUROPEAN UNION,
Having regard to the Treaty establishing the European Community, and in particular the second subparagraph of Article 152(4) thereof,
Having regard to the proposal from the Commission(1),
Having regard to the opinion of the European Parliament(2),
Having regard to the opinion of the European Economic and Social Committee(3),
Having regard to the opinion of the Committee of the Regions(4),
Whereas:
-
(1)In accordance with Article 3(1)(p) of the Treaty, Community action is to include a contribution towards the attainment of a high level of health protection. The third subparagraph of Article 152(1) of the Treaty also makes provision for action in reducing drugs-related health damage, including information and prevention.
-
(2)The European Council, meeting in Helsinki on 10 and 11 December 1999, endorsed the European Union Drugs Strategy 2000 - 2004 that covers all European Union drug-related activities and sets main targets. These targets include a substantial reduction over five years of the incidence of drug-related health damage (such as HIV, hepatitis B and C and tuberculosis) and the number of drug-related deaths.
-
(3)The European Council, meeting in Santa Maria da Feira on 19 and 20 June 2000, endorsed the European Union Action Plan on Drugs 2000 - 2004 as a crucial instrument for transposing the European Union Drugs Strategy 2000 - 2004 into concrete actions which provide an effective integrated and multi-disciplinary response to the drug problem.
-
(4)The Commission, in its Communication to the European Parliament and the Council on the European Union Action Plan to Combat Drugs (2000 - 2004), considered a comprehensive approach that should cover all areas of drug abuse prevention, from discouraging the initial use to reducing the negative health and social consequences as the best strategy.
-
(5)The European Parliament, in its Resolution on the abovementioned Communication welcomed the objective of reducing the number of deaths among addicts and called on the European Union and its Member States to encourage and develop damage limitation policies, without debarring individual Member States from adopting measures and pilot schemes in this area.
-
(6)The programme of Community action on the prevention of drug dependence within the framework for action in the field of public health and the programme of Community action on the prevention of AIDS and certain other communicable diseases within the framework for action in the field of public health have supported projects aimed at preventing and reducing the risks associated with drug dependence, in particular by encouraging cooperation between the Member States, supporting their action and promoting coordination between their policies and programmes. Both programmes have been contributing to improving information, education and training aimed at preventing drug dependence and the associated risks, in particular, for young people and particularly vulnerable groups.
-
(7)The decision of the European Parliament and of the Council adopting a programme of action in the field of public health (2003 - 2008) includes the development of strategies and measures on drug dependence, as one of the important lifestyle-related health determinants.
-
(8)Since, according to research, the morbidity and the mortality associated with drug dependence affects a sizeable number of European citizens, the health-related harm associated with drug dependence constitutes a major...
More
This text has been adopted from EUR-Lex.
This dossier is compiled each night drawing from aforementioned sources through automated processes. We have invested a great deal in optimising the programming underlying these processes. However, we cannot guarantee the sources we draw our information from nor the resulting dossier are without fault.
This page is also available in a full version containing the summary of legislation, the legal context, de Europese rechtsgrond, other dossiers related to the dossier at hand and finally the related cases of the European Court of Justice.
The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.
The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.